Drug class in one race
GLP-1 receptor drugs for Atherosclerotic Cardiovascular Disease
4 tracked GLP-1 receptor drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the GLP-1 receptor page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
3 approved / phase 41 Phase 3
Head-to-head evidence: dulaglutide vs semaglutide · liraglutide vs semaglutide · orforglipron vs semaglutide